NCT03309579.
Study name | Aneurysmal SubArachnoid Hemorrhage ‐ red blood cell transfusion and outcome (SAHaRA) |
Methods | RCT (multicentre; international; pragmatic) |
Participants | Adults with aneurysmal subarachnoid haemorrhage Estimated enrolment: 740 (including participants enrolled in earlier pilot (NCT02483351)) NCT02483351 is now complete; participants' results will be published when the main trial reports, not separately |
Interventions | Liberal vs restrictive threshold (10 g/dL vs 8 g/dL) |
Outcomes | Primary outcome: modified Rankin scale (for measuring functional outcome in stroke) Mortality will be reported at 12 months |
Starting date | 2018 |
Contact information | Shane English; senglish@toh.ca |
Notes | Trial registration (prospective): NCT03309579 Funding: supported by a Transfusion Science research grant awarded by a Canadian Blood Services and Health Canada in partnership with CIHR Institute of Circulatory and Respiratory Health (Canada) |